Showing results (1-10 of 487) with videos related to

Sort By:
Pageof 49
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 8, 2020
[Required Human and System Resources for Genomic Medicine]Eriko Aimono, Hiroshi Nishihara
Diagnostic Pathology|January 15, 2020
Aggressive prostate cancer with somatic loss of the homologous recombination repair gene FANCA: a case reportHiroshi Hongo, Takeo Kosaka, Eriko Aimono, et al.
Cancers|July 15, 2026
Real-World Data of Comprehensive Genomic Profiles and Clinicopathological Characteristics of Duodenal Epithelial NeoplasmsMarin Ishikawa, Hideyuki Hayashi, Kohei Nakamura, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 8, 2020
[Learning from My Experience: Outpatient Care for Cancer Multigene Genomic Testing]Eriko Aimono, Aki Iguchi, Kaori Mochida, et al.
Pathology International|March 27, 2023
The DNA integrity number and concentration are useful parameters for successful comprehensive genomic profiling test for cancer using formalin-fixed paraffin embedded tissueEmmy Yanagita, Hiroshi Yamada, Tetsuro Kobayashi, et al.
Diagnostic Pathology|May 30, 2020
Genetic profiling of patients with adenoid cystic carcinoma of the Bartholin's glands reveals potential new routes for targeted therapies: a case reportKohei Nakamura, Eriko Aimono, Shigeki Tanishima, et al.
International Journal of Molecular Sciences|March 6, 2021
Genetic Profiling of Malignant Melanoma Arising from an Ovarian Mature Cystic Teratoma: A Case ReportKohei Nakamura, Eriko Aimono, Reika Takamatsu, et al.
IJU Case Reports|July 14, 2021
Prominent response to platinum-based chemotherapy in a patient with <i>BRCA2</i> mutant-neuroendocrine prostate cancer and <i>MDM2</i> amplificationTatsuaki Daimon, Takeo Kosaka, Hiroshi Hongo, et al.
Ear, Nose, & Throat Journal|February 19, 2024
Salivary Duct Carcinoma Arising in the Submandibular Gland in a Patient with Neurofibromatosis Type 1Shuto Hayashi, Nobuyuki Bandoh, Misaki Hayashi, et al.
IJU Case Reports|January 10, 2022
First successful case of platinum-based chemotherapy for neuroendocrine prostate cancer with <i>BRCA2</i> and <i>PTEN</i> alterationsMinami Omura, Takeo Kosaka, Eriko Aimono, et al.
Pageof 49